GlassScriptPhysician profile
Joseph C Stuto
NPI 1689602344
$4,705.34
in general payments reported to CMS, 2019-2025
18 companies · $386 in 2025
The $386 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,259 · 2020: $882 · 2022: $264 · 2023: $574 · 2024: $340 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,475.34 | 2019 | |
| Acell, INC. | $795.62 | 2019-2020 | |
| Abbott Laboratories | $391.05 | 2022-2025 | Esprit, Diamondback Peripheral |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $344.04 | 2019-2020 | |
| Smith+Nephew, INC. | $304.33 | 2019-2023 | Regranex, Collagenase Santyl, Pico |
| Organogenesis INC. | $293.03 | 2022-2025 | Apligraf, Puraply |
| Horizon Therapeutics Plc | $253.95 | 2019-2020 | |
| Angiodynamics, INC. | $179.98 | 2024 | Auryon Laser System 100-120 Vac |
| Nevro Corp. | $144.44 | 2023 | Senza |
| Kerecis Limited | $143.05 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Amgen INC. | $122.21 | 2025 | Krystexxa |
| Djo, LLC | $53.23 | 2023 | Cmf |
| Journey Medical Corporation | $44.83 | 2024 | |
| Bioventus LLC | $41.25 | 2019 | |
| Integra Lifesciences Corporation | $39.81 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $39.75 | 2020 | |
| Sandoz INC. | $22.46 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.97 | 2023 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Stuto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.